Today (Monday Sept. 4th, 2017) Oracle released the latest version of Oracle Clinical 5.2, Oracle Clinical Remote Data Capture 5.2 and Thesaurus Management System 5.2.1.
TMS 5.2.1 (TMS 5.2 with patch for supporting WHODrug B3)
OC 5.2 and TMS 5.2 is primarily a technology stack upgrade from version 5.1 including some RDC bug-fixes, and hence no new functionality as such. However, TMS 5.2 comes with a patch (5.2.1) to support the new WHODrug B3 format, which was released on March 1st, 2017, and will replace the WHODrug B2 Enhanced Format. The dictionary vendor UMC will support WHODrug B2 until end of 2018.
Oracle are currently working on an OC 5.2 / TMS 5.2 version that are targeted for 2nd half of 2017. The 5.2 version comes with a technology update on the middle-tier now using Oracle WebLogic server 12c, and support for Microsoft Edge Web browser for Windows 10 on web-clients.
For existing customers on OC/TMS versions 4.6.6, 5.0.1 or 5.1, this is an opportunity to plan for a final and most likely last upgrade of OC/TMS from Oracle.
From release date of OC/TMS 5.2 you can expect 5 years of support.
Oracle are encouraging OC/TMS/RDC customers to switch to its Health Sciences solutions based on Oracle Life Sciences Hub (LSH), Data Management Workbench (DMW) and Inform (EDC cloud solution).
Oracle has recently announced that the TMS (Thesaurus Management System) coding system will be compliant with the new WHO Drug B3-format.
The changes needed will be made available for users six months prior to the B3-release (released on March 1st. 2017). Patches will be targeted for TMS versions 5.1.x, 5.0.1.x approximately six months before March 2017.
OC 4.6.6/TMS 4.6.6 will not be updated to support WHO Drug type B3 and long drug names – only OC 5.1/TMS 5.1.2 and OC 5.2/TMS5.2 (expected start Sept. 2017) will support the new WHO Drug B3 format.
Note: Drug names in WHO Drug B3 allows up to 1500 characters, but only the first 200 characters will be derived from TMS to OC. The percentage of drugs names exceeding 200 chars in WHO Drug B3 is less than 3%, so the risk for truncated drug name derived back to OC is small.